Amgen opens new biomanufacturing facility in Ohio, US

Betsy Goodfellow | February 27, 2024 | News story | Manufacturing and Production Amgen, Biomanufacturing, Manufacturing Facility, Ohio, Pharmacy, US 

Amgen has announced that it has opened a new manufacturing site in Central Ohio, US. This will be the latest development in the company’s global operations as well as its most advanced facility at present.

The facility is approximately 300,000 ft2 and is expected to employ 400 full-time staff. It will ‘feature open work spaces to foster collaboration and has been designed to meet the highest environmental sustainability standards’, according to the company’s press release.

Robert A Bradway, chairman and chief executive officer at Amgen, commented: “Our new facility, known as Amgen Ohio, was designed with the latest innovation and technology to deliver safe, reliable medicines for ‘every patient, every time’. As part of Amgen’s global biomanufacturing network, Amgen Ohio will play an important role in helping us address serious disease around the world with our innovative biomedicines.”

Lt Governor Jon Husted added: “This new Ohio facility is a success story in advanced healthcare manufacturing and the Made-in-America supply chain we need to live and thrive. Winning this project for Ohio creates 400 high-paying jobs and a $40 million annual payroll, supporting families and further growing the Ohio economy.”

Betsy Goodfellow

Related Content

FDA approves Amgen’s Imdelltra for extensive-stage small cell lung cancer

Amgen has announced that the US Food and Drug Administration (FDA) has approved Imdelltra (tarlatamab-dlle) …

Sanofi adds €1bn funding for biomanufacturing projects in France

Sanofi has announced that it has made a new investment of at least €1bn for …

Touchlight completes expansion of one of world’s largest DNA manufacturing facilities in London

Touchlight, a company that focuses on pioneering enzymatic DNA production, has announced that it has …

Latest content